Home Tags Cord Blood

Tag: Cord Blood

GoodCell Launches Personal Biobanking to Store Members' Stem Cells for Personalized Cell Therapies

GoodCell Launches Personal Biobanking to Store Members’ Stem Cells for Future Personalized Therapies

GoodCell, a life sciences company, launched Personal Biobanking, a proactive, preventative healthcare service that allows members to store their own stem cells for potential future personalized therapy.  Thousands of cell and gene therapies are in development to treat diseases and...

Cord Blood Registry Upgrading To ThermoGenesis’ Next-Generation AXP® II System

ThermoGenesis, a wholly owned subsidiary of Cesca Therapeutics and a market leader in automated cellular processing has announced that CBR® (Cord Blood Registry), the USA's largest newborn stem cell storage bank has begun the process to transition to ThermoGenesis' next-generation AXP® II System...

Gamida Cell Presented Omidubicel Cell Therapy For Blood Cancers At ISCT Meeting In Melbourne

Two presentations on omidubicel (formerly known as NiCord®), an investigational advanced cell therapy in Phase 3 clinical development designed to enhance the life-saving benefits of hematopoietic stem cell (bone marrow) transplant, developed by Gamida Cell Ltd., a leading cellular and immune therapeutics company,...

ExCellThera And NYBC’s Comprehensive Cell Solutions Enter Manufacturing Agreement

ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, has announced that it has entered into a manufacturing and collaboration agreement with Comprehensive Cell Solutions (CCS), a division of New...

Opportunity To Develop Nerve Agent Antidote At Scale From Human Umbilical Cord Cells

Aurora BioSolutions Inc. and Tissue Regeneration Therapeutics Inc. (TRT) have announced that they have discovered that human umbilical cord cells are a sustainable source of human butyrylcholinesterase (HuBChE), a bioscavenger that neutralizes organophosphate nerve toxins. Furthermore, the cells can...

Affimed To Present Innate Immune Engagers At AACR Meeting

Affimed N.V., a clinical stage biopharmaceutical company committed to improving patient outcomes through the power of the innate immune system, has announced that two abstracts from the Company’s innate cell engager program have been accepted for poster presentation at...

Magenta Therapeutics Presented MGTA-456 At Transplant And Cellular Therapy (TCT) Annual Meeting

Magenta Therapeutics has announced that the company presented Phase 2 clinical data and preclinical research on its MGTA-456 program at the TCT annual meeting. Founded in 2015, headquartered in Cambridge, Massachusetts, USA, Magenta Therapeutics is a clinical-stage biotechnology company developing...

Five-Compartment Cord Blood Freezing Bags From Americord Come With $110,000 Quality Guarantee

Americord Registry has announced that it will begin offering five-compartment freezing bags for all new customers storing cord blood as well as the highest quality guarantee in the industry. While industry-standard freezing bags typically contain two compartments, one holding...

Gamida Cell To Present Data On Cord Blood Derived NiCord® At The TCT Annual...

Gamida Cell Ltd. has announced that new data from its clinical programs will be presented at the 2019 Transplantation & Cellular Therapy (TCT) Meetings of American Society for Blood and Marrow Transplantation (ASBMT) and Center for International Blood and...

StemCyte Receives IND Clearance Of Mononuclear Stem Cells In Spinal Cord Injury Clinical Trials

On December 14, 2018, the U.S. Food and Drug Administration (FDA), approved StemCyte’s Phase II Investigational New Drug (IND) application for Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood Mononuclear Stem Cells (UCBMNC) (MC001) for the treatment of spinal cord injury. Founded in 1997,...

⭐ Recently Featured

🔥 Popular Posts

X